- Home
- MOB vs CRIS Comparison
MOB vs CRIS Comparison
Compare MOB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOB | CRIS |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.0M | 14.6M |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MOB | CRIS |
|---|---|---|
| Price | $7.03 | $1.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $10.00 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 337.5K | 110.0K |
| Earning Date | 08-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,826,361.00 | ★ $11,650,000.00 |
| Revenue This Year | $142.38 | $6.13 |
| Revenue Next Year | $99.99 | $8.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $6.59 | $1.02 |
| 52 Week High | $8.20 | $4.50 |
Technical Indicators
Market Signals| Indicator | MOB | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 50.13 | 40.13 |
| Support Level | $6.59 | $1.29 |
| Resistance Level | $8.15 | $1.41 |
| Average True Range (ATR) | 0.98 | 0.12 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 58.97 | 23.54 |
Price Performance
Historical ComparisonAbout MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.